Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive HIV-1-infected patients [1]

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1826-1828

  Riva, Elisabetta ^a   Antonelli, Guido ^b   Scagnolari, Carolina ^b   Pistello, Mauro ^e   Capobianchi, Maria Rosaria ^c   D'Arminio Monforte, Antonella ^f   Pezzotti, Patrizio ^d   Dianzani, Ferdinando ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CELL DNA; GENOMIC DNA; VIRUS DNA;

AGE DISTRIBUTION; BLOOD ANALYSIS; BLOOD CELL COUNT; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DNA DETERMINATION; DNA ISOLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; ITALY; LETTER; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; POPULATION EXPOSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX RATIO; STATISTICAL ANALYSIS; SURVIVAL; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; ITALY; MALE; RNA, VIRAL; VIRAL LOAD;

EID: 0038201918     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375251     Document Type: Letter

References (8)

1. Tierney C, Lathey JL, Christopherson C, et al. Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy. AIDS Clinical Trial Group. J Infect Dis 2003; 187:144-8.
2. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HW despite prolonged suppression of plasma viremia. Science 1997; 278:1295-300.
3. Natarajan V, Bosche M, Metcalf JA, Ward DJ, Lane HC, Kovacs JA. HW-1 replication in patients with undetectable plasma virus receiving HAART. Lancet 1999; 353:119-20.
4. Furtado MR, Callaway DS, Phair JP, et al. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 1999; 340:1614-22.
5. + T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. J Infect Dis 2002; 185: 1672-6.
6. Kostrikis LG, Touloumi G, Karanicolas R, et al. Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load. J Virol 2002; 76:10099-108.
7. Rive E, Pistello M, Narciso P, et al. Decay of HIV-1 DNA and development of drug-resistant mutants in patients with primary HIV-1 infection receiving highly antiretroviral therapy. AIDS Res Hum Retroviruses 2001; 17: 159-1604.
8. StataCorp. Stata Statistical Software: release 7.0. College Station, TX: State Corporation, 2001.